CIK: 0001821219 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value ($000): $137,054 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JPM | JPMORGAN CHASE | 245,000 | $40,104 | 29.3% | $81.74 | +71.6% | COMMON EQUITY | 46625H100 |
| BRK/A | BERKSHIRE HATHAWAY INC CL A | 33 | $13,576 | 9.9% | $313571.66 | +34.8% | COMMON EQUITY | 084670108 |
| WAL | WESTERN ALLIANCE BANCORP | 120,000 | $13,058 | 9.5% | $30.98 | +184.5% | COMMON EQUITY | 957638109 |
| BABA | ALIBABA GROUP HOLDING-SP ADR | 50,000 | $7,402 | 5.4% | $226.78 | — | COMMON EQUITY | 01609W102 |
| KKR | KKR | 100,000 | $6,088 | 4.4% | $25.46 | +137.6% | COMMON EQUITY | 48251W104 |
| ACGL | ARCH CAPITAL GROUP LTD | 150,000 | $5,727 | 4.2% | $31.21 | +20.7% | COMMON EQUITY | G0450A105 |
| GS | GOLDMAN SACHS GROUP INC | 15,000 | $5,670 | 4.1% | $164.18 | +113.1% | COMMON EQUITY | 38141G104 |
| — | CADENCE BANCORP | 250,000 | $5,490 | 4.0% | $8.86 | — | COMMON EQUITY | 12739A100 |
| OZK | BANK OZK | 125,000 | $5,372 | 3.9% | $17.43 | +103.8% | COMMON EQUITY | 06417N103 |
| — | AMRYT PHARMA LTD - SPNR ADR | 410,000 | $4,938 | 3.6% | $12.18 | — | COMMON EQUITY | 03217L106 |
| ACN | ACCENTURE PLC CL A | 15,000 | $4,799 | 3.5% | $174.62 | +75.0% | COMMON EQUITY | G1151C101 |
| AON | AON PLC CLASS A | 15,000 | $4,287 | 3.1% | $178.56 | +45.8% | COMMON EQUITY | G0403H108 |
| PGR | PROGRESSIVE CORP | 45,000 | $4,068 | 3.0% | $66.35 | +28.6% | COMMON EQUITY | 743315103 |
| SCHW | SCHWAB (CHARLES) CORP | 50,000 | $3,642 | 2.7% | $33.18 | +103.1% | COMMON EQUITY | 808513105 |
| C | CITIGROUP INC | 50,000 | $3,509 | 2.6% | $38.68 | +54.3% | COMMON EQUITY | 172967424 |
| WFC | WELLS FARGO | 70,000 | $3,249 | 2.4% | $23.98 | +73.4% | COMMON EQUITY | 949746101 |
| NTRS | NORTHERN TRUST CORP | 30,000 | $3,235 | 2.4% | $66.60 | +48.5% | COMMON EQUITY | 665859104 |
| — | ATAI LIFESCIENCES NV | 192,000 | $2,840 | 2.1% | $14.79 | — | COMMON EQUITY | N0731H103 |